Endocrine and anti-tumour effects in breast cancer patients treated neo-adjuvantly with the aromatase inhibitor, letrozole

被引：0
|
作者：
Miller, WR [1 ]
Dixon, JM [1 ]
Telford, J [1 ]
Marson, L [1 ]
Bellamy, C [1 ]
Kurian, K [1 ]
MacFarlane, L [1 ]
Anderson, TJ [1 ]
机构：
[1] Western Gen Hosp, Edinburgh Breast Unit, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
BRITISH JOURNAL OF CANCER | 1999年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P304
引用
收藏
页码：104 / 104
页数：1
相关论文
共 50 条
  • [1] Early changes in tumour Ki67 expression differentiate for pathological (but not clinical) response in breast cancers treated neo-adjuvantly with letrozole.
    Anderson, TJ
    Dixon, MJ
    Murray, J
    Renshaw, L
    White, S
    Miller, WR
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S50 - S50
  • [2] Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer
    Dowsett, M
    Pfister, C
    Johnston, SRD
    Miles, DW
    Houston, SJ
    Verbeek, JA
    Gundacker, H
    Sioufi, A
    Smith, IE
    CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2338 - 2343
  • [3] Neoadjuvant therapy of endometrial cancer with the aromatase inhibitor letrozole: endocrine and clinical effects
    Berstein, L
    Maximov, S
    Gershfeld, E
    Meshkova, I
    Gamajunova, V
    Tsyrlina, E
    Larionov, A
    Kovalevskij, A
    Vasilyev, D
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2002, 105 (02): : 161 - 165
  • [4] Early Breast Cancer in Elderly Women Treated with an Aromatase Inhibitor (Letrozole) as Sole Therapy
    Balakrishnan, A.
    Ravichandran, D.
    CANCER RESEARCH, 2010, 70
  • [5] Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy
    Balakrishnan, A.
    Ravichandran, D.
    BRITISH JOURNAL OF CANCER, 2011, 105 (12) : 1825 - 1829
  • [6] Early operable breast cancer in elderly women treated with an aromatase inhibitor letrozole as sole therapy
    A Balakrishnan
    D Ravichandran
    British Journal of Cancer, 2011, 105 : 1825 - 1829
  • [7] Anti-tumour and radiosensitising effects of PARP inhibitor on cervical cancer xenografts
    Qin, Xue
    Wang, Enyang
    Gong, Tingting
    Ma, Xiaolin
    Ma, Qipeng
    Gao, Song
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2023, 43 (01)
  • [8] Ocular Side Effects of Aromatase Inhibitor Endocrine Therapy in Breast Cancer - A Review
    Serban, Dragos
    Costea, Daniel Ovidiu
    Zgura, Anca
    Tudosie, Mihail Silviu
    Dascalu, Ana Maria
    Gangura, Gabriel Andrei
    Smarandache, Catalin Gabriel
    Sabau, Alexandru Dan
    Tudor, Corneliu
    Faur, Mihai
    Costea, Andreea Cristina
    Stana, Daniela
    Balasescu, Simona Andreea
    Tribus, Laura Carina
    Tanasescu, Ciprian
    IN VIVO, 2022, 36 (01): : 40 - 48
  • [9] CLINICAL AND ENDOCRINE EFFECTS OF THE ORAL AROMATASE INHIBITOR VOROZOLE IN POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    JOHNSTON, SRD
    SMITH, IE
    DOODY, D
    JACOBS, S
    ROBERTSHAW, H
    DOWSETT, M
    CANCER RESEARCH, 1994, 54 (22) : 5875 - 5881
  • [10] Single cell characterization of longitudinal biopsies from breast cancer patients treated with the aromatase inhibitor letrozole and the CDK4/6 inhibitor ribociclib
    Tekpli, X.
    Ghannoum, S.
    Steen, C. B.
    Fongard, M.
    Holm, B. C.
    Bosnjak, T.
    Reitsma, L. C.
    Geisler, S. B.
    Seyedzadeh, M.
    Buvarp, U-C.
    Loeng, M.
    Lyngra, M.
    Kristensen, V.
    Geisler, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1314 - S1315
12345